These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11837340)

  • 1. Symptoms associated with anthrax exposure: suspected "aborted" anthrax.
    Cymet TC; Kerkvliet GJ; Tan JH; Gradon JD
    J Am Osteopath Assoc; 2002 Jan; 102(1):41-3. PubMed ID: 11837340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up on "Symptoms associated with anthrax exposure: suspected 'aborted' anthrax".
    Cymet TC; Kerkvliet GJ
    J Am Osteopath Assoc; 2002 Apr; 102(4):203. PubMed ID: 12003462
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.
    Quintiliani R; Quintiliani R
    Conn Med; 2002 May; 66(5):261-7. PubMed ID: 12071107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1051-4. PubMed ID: 11808926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on anthrax exposure case report.
    McFee RB; Howell JT
    J Am Osteopath Assoc; 2002 Jul; 102(7):362-3; author reply 363-4. PubMed ID: 12138949
    [No Abstract]   [Full Text] [Related]  

  • 9. Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
    Schmitt B; Dobrez D; Parada JP; Kyriacou DN; Golub RM; Sharma R; Bennett C
    Arch Intern Med; 2007 Apr; 167(7):655-62. PubMed ID: 17420423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.
    Williams JL; Noviello SS; Griffith KS; Wurtzel H; Hamborsky J; Perz JF; Williams IT; Hadler JL; Swerdlow DL; Ridzon R
    Emerg Infect Dis; 2002 Oct; 8(10):1133-7. PubMed ID: 12396928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhalation anthrax in a textile worker: non-fatal course].
    Winter H; Pfisterer RM
    Schweiz Med Wochenschr; 1991 Jun; 121(22):832-5. PubMed ID: 1905838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical counterbioterrorism: the response to provide anthrax prophylaxis to New York City US Postal Service employees.
    Partridge R; Alexander J; Lawrence T; Suner S
    Ann Emerg Med; 2003 Apr; 41(4):441-6. PubMed ID: 12658240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax as a biological weapon: an old disease that poses a new threat.
    Tasota FJ; Henker RA; Hoffman LA
    Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 17. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the true number of victims of the postal anthrax attack of 2001?
    Cymet TC; Kerkvliet GJ
    J Am Osteopath Assoc; 2004 Nov; 104(11):452. PubMed ID: 15602039
    [No Abstract]   [Full Text] [Related]  

  • 19. What you should know. Confusion about anthrax and what to do about it abounds; here are answers, straight and up to date.
    Comarow A
    US News World Rep; 2001 Nov; 131(19):50-1. PubMed ID: 11710270
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.